Navigation Links
PRA Experts to Speak at Drug Safety Conference Breakout Session on Risk Management Strategies
Date:9/9/2011

RALEIGH, N.C., Sept. 9, 2011 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces that two experts from our Safety and Risk Management (SRM) group will present at the European World Drug Safety Congress being held in London from 13-16 September 2011.  PRA will also host an exhibit at booth #2, where additional SRM representatives will be available to discuss PRA's approach to pharmacovigilance.

Dr. Sabine Richter, PRA's Vice President of SRM, will chair the "Risk Management" breakout stream on day one of the event.  At 1:00PM BST, Dr. Richter will deliver opening remarks for the session, which will cover risk management plans, safety reporting, and risk-benefit balance during research and development.

Dr. Hemendra Misra, Director of Risk Management at PRA, will give a presentation titled, "Development Safety Update Reports (DSURs): The Time is Now" at 2:25PM BST.  Dr. Misra's speech will summarize new legal requirements and explain how a DSUR can be used as an effective tool for risk identification and assessment.

Dr. Richter has over 20 years of research experience in the pharmaceutical and clinical research industries as well as in academia. Since joining PRA's SRM team in 2004, she has delivered numerous projects for a variety of clients and led large, long-term safety programs involving as many as 50 countries on five continents. As the head of PRA's SRM group, Dr. Richter has developed robust procedures and quality control measures to ensure consistent high performance and regulatory compliance.

A pharmacovigilance physician with 15 years of international work experience, Dr. Misra's background includes positions at hospitals in India and with Medecins Sans Frontieres (Doctors Without Borders), as well as seven years of industry experience with both pharmaceutical and clinical research organizations.  Dr. Misra has also served as a medical monitor and conducted safety surveillance of marketed drugs as well as drugs in development.

PRA's SRM group provides services throughout the entire product life cycle. The team includes over 100 experts available to clients for consultancy as well as routine and specialty pharmacovigilance services. Most of these staff members are healthcare professionals (nurses, pharmacists, physicians) or life scientists.  PRA's drug safety centers are based in our Mannheim, Germany; Swansea, UK; Charlottesville, VA (US); and Sao Paulo, Brazil offices.

About PRA

PRA is transforming clinical trials through our people, innovation and transparency.  PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge.  Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs.  But at PRA, we are looking to the future, not the past.  Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email endpoints@praintl.com or call our Global Headquarters.


'/>"/>
SOURCE PRA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cancer Treatment Experts from Across Latin America Gather in Rio de Janeiro to Discuss Advances in Radiation Oncology
2. Renowned Experts to Share Early Insights Into Why Bariatric Surgery Improves Type 2 Diabetes for Many Patients
3. Texas & U.S. Drug Treatment Gap to Be Highlighted at News Conference 11 a.m. June 23 By Former U.S. Drug Czar, U.S. Music Industry/Grammys Addiction Services Leader, Miss Texas 2007, San Antonio Police Chief, Nations Leading Treatment CEO, Experts
4. PharmaNet Experts to Showcase Bioanalytical Posters at ASMS 2011
5. UBM Canons Pharmalot Brings Together a Virtual Panel of Experts to Discuss the Procurement Experience
6. Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
7. PRA International Experts to Speak at Drug Safety Conference
8. Healthcare Providers, Technology Experts Call for Use of Existing Decision Support Tools to Promote Diagnostic Imaging Appropriate Use
9. PRA International Experts to Chair BioPharma Asia Panels
10. PRA International Experts to Speak at Industry Events
11. PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):